Drug Trials Snapshots: JESDUVROQ
Summary
JESDUVROQ is a hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor that treats anemia due to chronic kidney disease (CKD) in adults who have been rec...
Description
JESDUVROQ is a hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitor that treats anemia due to chronic kidney disease (CKD) in adults who have been rec...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source